Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Itakura

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
Oncology|November 26, 2011
Early decrease in α-fetoprotein, but not des-γ-carboxy prothrombin, predicts sorafenib efficacy in patients with advanced hepatocellular carcinomaTeiji Kuzuya, Yasuhiro Asahina, Kaoru Tsuchiya, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infectionYasuhiro Asahina, Kaoru Tsuchiya, Nobuharu Tamaki, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|June 7, 2013
[A case of systemic amyloidosis with cholangiectasis diagnosed by liver biopsy]Yuji Kawano, Yutaka Yasui, Kaoru Tsuchiya, et al.
Plos One|June 19, 2018
Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinomaHitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2011
Changes in hepatitis C viral load during first 14 days can predict the undetectable time point of serum viral load by pegylated interferon and ribavirin therapyJun Itakura, Yasuhiro Asahina, Nobuharu Tamaki, et al.
World Journal of Gastroenterology|January 25, 2013
Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapyTakanori Hosokawa, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 16, 2014
L-carnitine Reduces Muscle Cramps in Patients With CirrhosisHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 10, 2020
Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosisNobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2018
Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance ElastographyMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
World Journal of Surgical Oncology|November 13, 2020
Anastomosis technique for pancreatojejunostomy and early removal of drainage tubes may reduce postoperative pancreatic fistulaHiromichi Kawaida, Hiroshi Kono, Hidetake Amemiya, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Oncology|November 26, 2011
Early decrease in α-fetoprotein, but not des-γ-carboxy prothrombin, predicts sorafenib efficacy in patients with advanced hepatocellular carcinomaTeiji Kuzuya, Yasuhiro Asahina, Kaoru Tsuchiya, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infectionYasuhiro Asahina, Kaoru Tsuchiya, Nobuharu Tamaki, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|June 7, 2013
[A case of systemic amyloidosis with cholangiectasis diagnosed by liver biopsy]Yuji Kawano, Yutaka Yasui, Kaoru Tsuchiya, et al.
Plos One|June 19, 2018
Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinomaHitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2011
Changes in hepatitis C viral load during first 14 days can predict the undetectable time point of serum viral load by pegylated interferon and ribavirin therapyJun Itakura, Yasuhiro Asahina, Nobuharu Tamaki, et al.
World Journal of Gastroenterology|January 25, 2013
Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapyTakanori Hosokawa, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 16, 2014
L-carnitine Reduces Muscle Cramps in Patients With CirrhosisHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 10, 2020
Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosisNobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2018
Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance ElastographyMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
World Journal of Surgical Oncology|November 13, 2020
Anastomosis technique for pancreatojejunostomy and early removal of drainage tubes may reduce postoperative pancreatic fistulaHiromichi Kawaida, Hiroshi Kono, Hidetake Amemiya, et al.
Pageof 13